Arcellx Inc (ACLX)

전일 마감가:

$52.42

열려 있는:

$52.08

하루 거래량:

355.87K

시가총액:

$2.78B

수익:

-

순이익/손실:

$-70.36M

주가수익비율:

-13.19

EPS:

-3.96

순현금흐름:

$186.15M

1주 성능:

+0.13%

1개월 성능:

-13.85%

6개월 성능:

+13.93%

1년 성능:

+20.87%

1일 변동 폭

$50.73

$52.65

52주 변동 폭

$30.74

$75.10

Arcellx Inc Stock (ACLX) Company Profile

명칭

Arcellx Inc

부문

Healthcare (1211)

산업

Biotechnology (697)

전화

240-327-0603

주소

25 West Watkins Mill Road, Suite A, Gaithersburg

직원

0

트위터

다음 수익 날짜

최신 SEC 제출 서류

ACLX's Discussions on Twitter

Arcellx Inc Stock (ACLX) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2024-01-04	재확인	Needham	Buy
2023-12-19	개시	Scotiabank	Sector Outperform
2023-10-30	개시	TD Cowen	Outperform
2023-10-17	개시	UBS	Buy
2023-05-18	개시	Truist	Buy
2023-04-14	개시	Robert W. Baird	Outperform
2023-03-14	개시	Stifel	Buy
2023-02-13	개시	H.C. Wainwright	Buy
2022-12-13	재개	BofA Securities	Buy
2022-10-31	개시	Guggenheim	Buy
2022-10-27	개시	Needham	Buy
2022-07-20	개시	Canaccord Genuity	Buy
2022-03-01	개시	BofA Securities	Buy
2022-03-01	개시	SVB Leerink	Outperform

모두보기

Arcellx Inc 주식(ACLX)의 최신 뉴스

Sarepta Therapeutics (SRPT) Q1 Earnings and Revenues Beat Estimates

Zacks Investment Research

How Arcellx (ACLX) Stock Stands Out in a Strong Industry

Zacks Investment Research

Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley

Benzinga

Arcellx, Inc. (ACLX) Q4 Earnings and Revenues Surpass Estimates

Zacks Investment Research

Blood Cancer Player Arcellx Finds Place On Analyst Conviction List - Potential Room For Growth In 2024

Benzinga

Needham Maintains Buy Rating for Arcellx: Here's What You Need To Know

Benzinga

Arcellx Inc (ACLX) 재무 분석

Arcellx Inc (ACLX) 순이익 2024

Arcellx Inc (ACLX) 현금흐름 2024

Arcellx Inc (ACLX) 주당 순이익 2024